REFERENCES
1. Braun, J. M. Early-life exposure to EDCs: role in childhood obesity and neurodevelopment. Nat. Rev. Endocrinol. 2017, 13, 161-73.
2. Souter, I.; Smith, K. W.; Dimitriadis, I.; et al. The association of bisphenol-A urinary concentrations with antral follicle counts and other measures of ovarian reserve in women undergoing infertility treatments. Reprod. Toxicol. 2013, 42, 224-31.
3. Berghuis, S. A.; Bos, A. F.; Groen, H.; et al. Prenatal environmental exposure to persistent organic pollutants and reproductive hormone profile and pubertal development in Dutch adolescents. Int. J. Environ. Res. Public. Health. 2022, 19, 9423.
4. Lecante, L. L.; Leverrier-Penna, S.; Gicquel, T.; et al. Acetaminophen (APAP, paracetamol) interferes with the first trimester human fetal ovary development in an ex vivo model. J. Clin. Endocrinol. Metab. 2022, 107, 1647-61.
5. Rebuzzini, P.; Fabozzi, G.; Cimadomo, D.; et al. Multi- and transgenerational effects of environmental toxicants on mammalian reproduction. Cells 2022, 11, 3163.
6. Rogers, R. E.; Chai, S.; Pask, A. J.; Mattiske, D. M. Prenatal exposure to diethylstilbestrol has long-lasting, transgenerational impacts on fertility and reproductive development. Toxicol. Sci. 2023, 195, 53-60.
7. Hassan, S.; Thacharodi, A.; Priya, A.; et al. Endocrine disruptors: unravelling the link between chemical exposure and Women’s reproductive health. Environ. Res. 2024, 241, 117385.
8. OECD. Detailed review paper on the state of the science on novel in vitro and in vivo screening and testing methods and endpoints for evaluating endocrine disruptors. 2012. https://www.oecd.org/en/publications/detailed-review-paper-on-the-state-of-the-science-on-novel-in-vitro-and-in-vivo-screening-and-testing-methods-and-endpoints-for-evaluating-endocrine-disruptors_9789264221352-en.html. (accessed 2026-11-09).
9. OECD. Revised guidance document 150 on standardised test guidelines for evaluating chemicals for endocrine disruption. 2018. https://www.oecd.org/en/publications/guidance-document-on-standardised-test-guidelines-for-evaluating-chemicals-for-endocrine-disruption-2nd-edition_9789264304741-en.html. (accessed 2026-11-09).
10. Johansson, H. K. L.; Damdimopoulou, P.; van Duursen, M. B. M.; et al. Putative adverse outcome pathways for female reproductive disorders to improve testing and regulation of chemicals. Arch. Toxicol. 2020, 94, 3359-79.
11. Lorenzetti, S.; Marcoccia, D.; Mantovani, A. Biomarkers of effect in endocrine disruption: how to link a functional assay to an adverse outcome pathway. Ann. Ist. Super. Sanita. 2015, 51, 167-71.
12. Parent, A. S.; Damdimopoulou, P.; Johansson, H. K. L.; et al. Endocrine-disrupting chemicals and female reproductive health: a growing concern. Nat. Rev. Endocrinol. 2025, 21, 593-607.
13. Toporova, L.; Balaguer, P. Nuclear receptors are the major targets of endocrine disrupting chemicals. Mol. Cell. Endocrinol. 2020, 502, 110665.
14. Lallous, N.; Leblanc, E.; Munuganti, R. S.; et al. Targeting binding function-3 of the androgen receptor blocks its co-chaperone interactions, nuclear translocation, and activation. Mol. Cancer. Ther. 2016, 15, 2936-45.
15. Riley, C. M.; Elwood, J. M. L.; Henry, M. C.; et al. Current and emerging approaches to noncompetitive AR inhibition. Med. Res. Rev. 2023, 43, 1701-47.
16. Dusza, H. M.; Janssen, E.; Kanda, R.; Legler, J. Method development for effect-directed analysis of endocrine disrupting compounds in human amniotic fluid. Environ. Sci. Technol. 2019, 53, 14649-59.
17. Plešnik, H.; Rekar, Ž.; Stevanović, S.; et al. Nontargeted urinary profiling strategy for endocrine-disrupting chemicals in women with ovarian malignancies. Environ. Sci. Technol. 2025, 59, 8380-90.
18. Weyrich, A.; Joel, M.; Lewin, G.; Hofmann, T.; Frericks, M. Review of the state of science and evaluation of currently available in silico prediction models for reproductive and developmental toxicity: a case study on pesticides. Birth. Defects. Res. 2022, 114, 812-42.
19. Pan, J.; Liu, P.; Yu, X.; Zhang, Z.; Liu, J. The adverse role of endocrine disrupting chemicals in the reproductive system. Front. Endocrinol. 2023, 14, 1324993.
20. Mínguez-Alarcón, L.; Gaskins, A. J. Female exposure to endocrine disrupting chemicals and fecundity: a review. Curr. Opin. Obstet. Gynecol. 2017, 29, 202-11.
21. Cai, A.; Remy, S.; Lenters, V.; et al. Exposure to a mixture of endocrine-disrupting chemicals and metabolic outcomes in Belgian adolescents. Environ. Sci. Technol. 2023, 57, 19871-80.
22. Tyagi, P.; James-Todd, T.; Mínguez-Alarcón, L.; et al.; EARTH study team. Identifying windows of susceptibility to endocrine disrupting chemicals in relation to gestational weight gain among pregnant women attending a fertility clinic. Environ. Res. 2021, 194, 110638.
23. De Vries, R. B. M.; Angrish, M.; Browne, P.; et al. Applying evidence-based methods to the development and use of adverse outcome pathways. ALTEX 2021, 38, 336-47.
24. Caserta, D.; Costanzi, F.; De Marco, M. P.; et al. Effects of endocrine-disrupting chemicals on endometrial receptivity and embryo implantation: a systematic review of 34 mouse model studies. Int. J. Environ. Res. Public. Health. 2021, 18, 6840.
25. Aldad, T. S.; Rahmani, N.; Leranth, C.; Taylor, H. S. Bisphenol-A exposure alters endometrial progesterone receptor expression in the nonhuman primate. Fertil. Steril. 2011, 96, 175-9.
26. Peng, H.; Sun, J.; Alharbi, H. A.; Jones, P. D.; Giesy, J. P.; Wiseman, S. Peroxisome proliferator-activated receptor γ is a sensitive target for oil sands process-affected water: effects on adipogenesis and identification of ligands. Environ. Sci. Technol. 2016, 50, 7816-24.
27. Eguchi, A.; Sakurai, K.; Yamamoto, M.; Mori, C. Elucidation of endogenous and exogenous chemicals in maternal serum using high-resolution mass spectrometry. Ecotoxicol. Environ. Saf. 2024, 286, 117256.
28. Ismaiel, O. A.; Zhang, T.; Jenkins, R. G.; Karnes, H. T. Investigation of endogenous blood plasma phospholipids, cholesterol and glycerides that contribute to matrix effects in bioanalysis by liquid chromatography/mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci. 2010, 878, 3303-16.
29. Panuwet, P.; Hunter, R. E. Jr.; D’Souza, P. E.; et al. Biological matrix effects in quantitative tandem mass spectrometry-based analytical methods: advancing biomonitoring. Crit. Rev. Anal. Chem. 2016, 46, 93-105.
30. Zhao, F.; Li, L.; Lin, P.; et al. HExpPredict: in vivo exposure prediction of human blood exposome using a random forest model and its application in chemical risk prioritization. Environ. Health. Perspect. 2023, 131, 37009.
31. Muncke, J. Endocrine disrupting chemicals and other substances of concern in food contact materials: an updated review of exposure, effect and risk assessment. J. Steroid. Biochem. Mol. Biol. 2011, 127, 118-27.
32. Groh, K. J.; Geueke, B.; Martin, O.; Maffini, M.; Muncke, J. Overview of intentionally used food contact chemicals and their hazards. Environ. Int. 2021, 150, 106225.
33. Collins, S. P.; Barton-Maclaren, T. S. Novel machine learning models to predict endocrine disruption activity for high-throughput chemical screening. Front. Toxicol. 2022, 4, 981928.
34. Stanojević, M.; Sollner Dolenc, M.; Vračko, M. Predictive models for compound binding to androgen and estrogen receptors based on counter-propagation artificial neural networks. Toxics 2023, 11, 486.
35. Ikeda, A.; Yamaguchi, T.; Ait Bamai, Y.; et al. Phosphate flame retardants and plasticizers and their association with reproductive and steroid hormone levels among peripubertal-aged children: the Hokkaido birth cohort study. Environ. Sci. Technol. 2025, 59, 4820-31.
